Results 121 to 130 of about 19,748 (182)

Hepatic-Predominant Immunoglobulin G Lambda Light Chain Amyloidosis Associated With Multiple Myeloma: A Report of an Exceptionally Rare Case. [PDF]

Cureus
Jesus G, Soares I, Silva AS, Baptista M, Gonçalves Ribeiro A.   +4 more
europepmc   +1 more source

Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis. [PDF]

Ann Med
Li X, Chen M, Liu J, Gu J, Huang B, Kuang L, Li J.   +6 more
europepmc   +1 more source

BCMA CAR-T: From Multiple Myeloma to Light-Chain Amyloidosis. [PDF]

Curr Oncol
Lewis E, Jimenez-Zepeda VH.
europepmc   +1 more source

A retrospective real-world study assessing diagnostic pattern of light-chain amyloidosis in Japan based on data from the medical data vision claims database. [PDF]

Ther Adv Hematol
Yogo M, Kasahara-Kiritani M, Oshima K, Ishida T.   +3 more
europepmc   +1 more source

Proving Bone Marrow Plasma Cell Clonality by Flow Cytometry: An Important Tool in the Diagnosis of Immunoglobulin Light-Chain Amyloidosis. [PDF]

Biomedicines
Badelita SN, Sandu HM, Coriu D, Jercan A, Barbu S, Zidaru L, Himcinschi ME, Dobrea C, Popescu M, Popa DC.   +9 more
europepmc   +1 more source

The Association of Kidney Function on Survival in Patients with Amyloid Light Chain Amyloidosis after Autologous Stem Cell Transplantation: A Multicenter Study. [PDF]

Kidney360
Selamet U, Joachim K, Lin H, Rondon G, Martinez CS, Delgado R, Page V, Motwani SS, Dincer B, Bianchi G, Qazilbash M, Murakami N, Abudayyeh A.   +12 more
europepmc   +1 more source

Renal heavy and light chain amyloidosis: A rare case report. [PDF]

Medicine (Baltimore)
Chen B, Wang J, Zang W, Wang C, Li J, Yang R.   +5 more
europepmc   +1 more source

Simultaneous onset of systemic sclerosis and light chain amyloidosis: the first report of a case report and review of the literature. [PDF]

Rheumatol Int
Colangelo A, Tromby F, Agliani E, Bruno L, Cafaro G, Crusco F, Mengoni A, Zuchi C, Gerli R, Bartoloni E, Perricone C.   +10 more
europepmc   +1 more source

Empagliflozin combined with bortezomib in the treatment of heavy and light chain amyloidosis with secondary diabetes: A case report. [PDF]

Medicine (Baltimore)
Zhang N, Zhang N, Luo L, Li Y, Ji C, Yuan C.   +5 more
europepmc   +1 more source

Incidence and prevalence of light chain amyloidosis in the United States in 2019-2021 using Optum EHR data. [PDF]

Sci Rep
Laires PA, Fang S, Evans J, Thompson J, Gaur A, Staruk B, Gupta A, Manwani R.   +7 more
europepmc   +1 more source